"10.1371_journal.pone.0089088","plos one","2014-02-26T00:00:00Z","Pere Domingo; María del Mar Gutierrez; José Miguel Gallego-Escuredo; Ferran Torres; Gracia María Mateo; Joan Villarroya; Ignacio de los Santos; Joan Carles Domingo; Francesc Villarroya; Luis Del Rio; Vicente Estrada; Marta Giralt","Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Biochemistry and Molecular Biology and Institute of Biomedicine, University of Barcelona, Barcelona, Spain; Biostatistics and Data Management Platform, Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Biostatistics Unit, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Institut de Recerca del Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Infectious Diseases Unit, Hospital de la Princesa, Madrid, Spain; CETIR, Barcelona, Spain; Infectious Diseases Unit, Hospital Clínico de San Carlos, Madrid, Spain; Institute of Biomedicine, University of Barcelona, Barcelona, Spain; Fisiopatología de la Obesidad y Nutrición, Centros de Investigación Biomédica en Red (CIBER), Santiago de Compostela, Spain","Conceived and designed the experiments: PD MdMG FV VE MG. Performed the experiments: PD MdMG FV VE MG. Analyzed the data: PD MdMG FV VE MG. Contributed reagents/materials/analysis tools: JMG-E FT GMM JV IdelS JCD LdR. Wrote the paper: PD MdMG FV VE MG.","This study was partly funded by an unrestricted grant from Merck, Sharp & Dohme, Spain, the producer of raltegravir. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","02","Pere Domingo","PD",12,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
